• Je něco špatně v tomto záznamu ?

Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus

V. Blaha, F. Musil, A. Smahelova, A. Ticha, R. Hyspler, M. Haluzik, J. Lesna, L. Sobotka,

. 2012 ; 33 Suppl 2 () : 6-12.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024118

Grantová podpora
NT12287 MZ0 CEP - Centrální evidence projektů

OBJECTIVES: The influence of body fat reduction on adipocyte fatty acid-binding protein (A-FABP) in obese patients with type 1 diabetes mellitus (T1DM) was investigated to examine whether it relates to the etiopathogenesis of insulin resistance (IR) and obesity. METHODS: We studied 14 obese patients with T1DM and IR (42.6±9.4 years, BMI 32.4±2.1 kg/m2) and 13 non-obese control patients with T1DM (36.9±13.9 years, BMI 22.6±2.1 kg/m2). Plasma FABP was measured by ELISA and plasma free fatty acids (FFA) were measured spectrophotometrically before weight reduction, immediately after 7 days of fasting and after 21 days on a low-calorie diet. The control group was studied only after overnight fasting. Body composition was examined using bioimpedance spectroscopy. The means ± SD, T-test, one-way ANOVA and Spearman's correlation were used for statistical evaluation. RESULTS: All patients tolerated the period of fasting. Obese T1DM patients lost 6.1±1.1 kg. There was a significant decrease in body mass index and body fat measured 21 days after weight reduction (p<0.05). Plasma FABP and FFA concentrations in obese T1DM patients before weight reduction were significantly higher than in controls, further increased significantly after fasting (p<0.05) and were restored thereafter. Significant positive correlations between FABP and FFA and between FABP and BMI (p<0.05) were found. CONCLUSION: Increased plasma FABP indicates insulin resistance in obese patients with T1DM. Weight reduction in T1DM patients is associated with a desirable decrease of body fat and transiently increased FABP. This increase might be a temporary adaptation of metabolism to non-stress fasting.

000      
00000naa a2200000 a 4500
001      
bmc13024118
003      
CZ-PrNML
005      
20190816085637.0
007      
ta
008      
130703s2012 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)23183502
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Bláha, Vladimír, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1964- $7 xx0002944
245    10
$a Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus / $c V. Blaha, F. Musil, A. Smahelova, A. Ticha, R. Hyspler, M. Haluzik, J. Lesna, L. Sobotka,
520    9_
$a OBJECTIVES: The influence of body fat reduction on adipocyte fatty acid-binding protein (A-FABP) in obese patients with type 1 diabetes mellitus (T1DM) was investigated to examine whether it relates to the etiopathogenesis of insulin resistance (IR) and obesity. METHODS: We studied 14 obese patients with T1DM and IR (42.6±9.4 years, BMI 32.4±2.1 kg/m2) and 13 non-obese control patients with T1DM (36.9±13.9 years, BMI 22.6±2.1 kg/m2). Plasma FABP was measured by ELISA and plasma free fatty acids (FFA) were measured spectrophotometrically before weight reduction, immediately after 7 days of fasting and after 21 days on a low-calorie diet. The control group was studied only after overnight fasting. Body composition was examined using bioimpedance spectroscopy. The means ± SD, T-test, one-way ANOVA and Spearman's correlation were used for statistical evaluation. RESULTS: All patients tolerated the period of fasting. Obese T1DM patients lost 6.1±1.1 kg. There was a significant decrease in body mass index and body fat measured 21 days after weight reduction (p<0.05). Plasma FABP and FFA concentrations in obese T1DM patients before weight reduction were significantly higher than in controls, further increased significantly after fasting (p<0.05) and were restored thereafter. Significant positive correlations between FABP and FFA and between FABP and BMI (p<0.05) were found. CONCLUSION: Increased plasma FABP indicates insulin resistance in obese patients with T1DM. Weight reduction in T1DM patients is associated with a desirable decrease of body fat and transiently increased FABP. This increase might be a temporary adaptation of metabolism to non-stress fasting.
650    _2
$a tukové buňky $x metabolismus $7 D017667
650    _2
$a tuková tkáň $x metabolismus $7 D000273
650    _2
$a dospělí $7 D000328
650    _2
$a složení těla $x fyziologie $7 D001823
650    _2
$a diabetes mellitus 1. typu $x farmakoterapie $x metabolismus $7 D003922
650    _2
$a redukční dieta $7 D004038
650    _2
$a omezení příjmu potravy $x fyziologie $7 D005215
650    _2
$a proteiny vázající mastné kyseliny $x krev $7 D050556
650    _2
$a kyseliny mastné neesterifikované $x krev $7 D005230
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glykemický clamp $7 D015309
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x aplikace a dávkování $7 D007004
650    _2
$a inzulin $x aplikace a dávkování $7 D007328
650    _2
$a inzulinová rezistence $x fyziologie $7 D007333
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x dietoterapie $x metabolismus $7 D009765
650    _2
$a hmotnostní úbytek $x fyziologie $7 D015431
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Musil, František, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1974- $7 xx0076218
700    1_
$a Šmahelová, Alena, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1952- $7 skuk0001359
700    1_
$a Tichá, Alena, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1976- $7 xx0076494
700    1_
$a Hyšpler, Radomír, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1972- $7 nlk20040155091
700    1_
$a Haluzík, Martin, $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $d 1970- $7 xx0000707
700    1_
$a Förstlová, Jana $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $7 xx0211829
700    1_
$a Sobotka, Luboš, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1952- $7 jn20001005317
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 2(2012), s. 6-12
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23183502 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20190816085906 $b ABA008
999    __
$a ok $b bmc $g 987798 $s 822498
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 33 Suppl 2 $d 6-12 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
GRA    __
$a NT12287 $p MZ0
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...